CLINICIAN ATRIAL FLUTTER GUIDE · SECTION 3 OF 3
Rhythm control interrupts the flutter. Rate control slows the ventricular response. Anticoagulation addresses stroke risk. Each has a different role.
Electrical cardioversion can rapidly restore sinus rhythm.
However, cardioversion does not eliminate the pathway responsible for flutter. The rhythm may return because the circuit remains available.
For elective cardioversion, the treating team must address anticoagulation and possible atrial thrombus before proceeding.
Typical flutter depends on conduction through the cavotricuspid isthmus (CTI) in the right atrium.
During ablation, the EP creates a line of conduction block across the CTI, between the tricuspid annulus and inferior vena cava. The goal is bidirectional block, preventing conduction across the line in either direction.
The electrical signal is running around a racetrack. CTI ablation closes a critical section of the track so the signal can no longer complete the lap.
Typical flutter ablation offers a high likelihood of durable control of that circuit. It is an important option for symptomatic flutter or flutter that is difficult to rate-control—not something that must wait until multiple medications fail.
Atypical flutter does not depend on the CTI. Its circuit may travel around the mitral annulus, the left atrial roof, surgical scar, or previous ablation lines.
The EP uses three-dimensional mapping to identify the circuit and its critical conduction pathway.
A CTI line alone will not treat a flutter circuit that does not use the CTI. Treatment must match the mechanism.
Atypical flutter ablation is generally more complex. Outcomes depend on the circuit, underlying atrial disease, and prior procedures; recurrence or repeat treatment may occur.
Rate-control medications may reduce the ventricular rate while a rhythm strategy is arranged.
Antiarrhythmic medications may help restore or maintain sinus rhythm in selected patients. Their selection depends on ventricular function, coronary disease, kidney function, QT interval, interactions, and other factors.
For typical flutter, discuss ablation early rather than assuming indefinite medication escalation is the only option.
Successful CTI ablation treats the typical flutter circuit. It does not isolate pulmonary-vein triggers or eliminate the underlying tendency to develop AFib.
Patients may have AFib before flutter ablation or develop it afterward.
“We can treat this flutter circuit very effectively. You may still develop other atrial rhythms, including AFib, so follow-up remains important.”
After cardioversion or ablation:
Do not stop anticoagulation simply because the flutter was successfully ablated. The decision requires assessment of stroke risk, AFib history, and ongoing surveillance.
Typical flutter: identify the circuit and discuss ablation early.
Atypical flutter: refer for individualized mapping and treatment.
Both: protect against stroke and maintain follow-up.
Reviewed October 11, 2026. Educational reference; apply current guidelines and individual clinical judgment.